Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The provided target name "Heme Polymerase-protoporphyrin IX)" appears to be a misnomer or does not correspond to any known enzyme, receptor, or drug target in biochemical or pharmacological literature. \n- Protoporphyrin IX (PPIX): A heterocyclic tetrapyrrole compound, the immediate precursor to heme, formed in the mitochondria by the action of protoporphyrinogen oxidase on protoporphyrinogen IX, with iron incorporation by ferrochelatase to produce heme. \n- No enzyme called "Heme Polymerase" exists. Key enzymes in heme biosynthesis include ALA synthase, uroporphyrinogen decarboxylase, coproporphyrinogen oxidase, protoporphyrinogen oxidase, and ferrochelatase. \n- PPIX plays a role in oxygen transport (as the prosthetic group in hemoglobin after iron insertion) and in photodynamic therapy. \n- If you wish to retrieve information for "Protoporphyrin IX," use this term directly for accurate scientific information.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heme Polymerase-protoporphyrin IX).